Banzel 400 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F9CX3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,156
Award facts
- Contract value 100% obligated
- $27,155.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 24, 2025, for the supply of Banzel 400 mg tablets (120-count units) with a ceiling value of $27,155.72. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of November 25, 2025.
This contract falls within AmerisourceBergen's role as a pharmaceutical prime vendor supplying critical medical commodities to support military and federal healthcare systems. Banzel (rufinamide) is a neurological treatment medication utilized within the Defense Health Agency's medical supply chain to serve active duty personnel, veterans, and other eligible beneficiaries. The award underscores AmerisourceBergen's established capability to fulfill federal pharmaceutical procurement requirements through competitive processes and its strategic position within the DLA's global pharmaceutical support network, which enables the delivery of specialty medications, brand-name and generic drugs, and other essential healthcare products across multiple therapeutic domains worldwide.
Quick answers
Who was awarded contract SPE2DR26F9CX3?
SPE2DR26F9CX3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F9CX3 worth?
The government has obligated $27,156 on SPE2DR26F9CX3.
Is contract SPE2DR26F9CX3 an order under another contract?
Yes. SPE2DR26F9CX3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9CX3 competed?
The extent of competition for SPE2DR26F9CX3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award